Parkinson’s Disease Mild Cognitive Impairment with MRI evidence of Cholinergic Nucleus 4 Degeneration: A New Subtype?
Quantitative Assessment of Facial Expression Asymmetry in Parkinson’s Disease
Male sex accelerates cognitive decline in GBA1 Parkinson’s Disease
Mapping of catecholaminergic denervation, neurodegeneration, and inflammation in 6-OHDA-treated Parkinson's disease mice
A network-based systems genetics framework identifies pathobiology and drug repurposing in Parkinson’s disease
Glymphatic dysfunction evidenced by DTI-ALPS is related to obstructive sleep apnea intensity in newly diagnosed Parkinson’s disease
Parkinson’s disease is characterized by vitamin B6-dependent inflammatory kynurenine pathway dysfunction
Investigating Motor Complications and Thyroid Hormones, Sex Hormonal/Menstrual Links in Female Parkinson's Patients
The LRRK2 p.L1795F variant causes Parkinson’s disease in the European population
Clinical and functional evidence for the pathogenicity of the LRRK2 p.Arg1067Gln variant